İsrail - İbranice - Ministry of Health

dexcel ltd, israel - lamotrigine - טבליות הניתנות לפיזור\לעיסה - lamotrigine 200 mg - lamotrigine - lamotrigine - epilepsy : monotherapy in adults and children over 12 years of age : simple partial seizures. complex partial seizures. generalised tonic clonic secondarily seizures. primary generalised tonic clonic seizures. add-on therapy in adults and children over 2 years of age: simple partial seizures. complex partial seizures. secondarily generalised tonic clonic seizures. adults (18 years of age and over) lamotrigine is indicated for the prevention of mood episodes in patients with bipolar disorder predominantly by preventing depressive episodes.

İsrail - İbranice - Ministry of Health

j-c health care ltd - risperidone - תמיסה - risperidone 1 mg / 1 ml - risperidone - risperidone - risperdal is indicated for the management of schizophrenia and manifestation of psychotic disorders. the antipsychotic efficacy of risperdal was established in short-term (6 to 8-weeks) controlled trials of schizophrenic inpatients. risperdal is also effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response.risperdal is indicated for the short-term treatment (up to 6 weeks) of persistent aggression in patients with moderate to severe alzheimer’s dementia unresponsive to non-pharmacological approaches and when there is a risk of harm to self or others. conduct and other disruptive disorders: treatment of behavioral disorders expressed by impulse control disorders or self-alienated-aggressive or treatment-requiring behavioral disorders with reduced or substandard intelligence. treatment should not be given to children under the age of 5 years.risperdal is indicated for the treatment of mania in bipolar disorder. these episodes are char

İsrail - İbranice - Ministry of Health

dexcel pharma technologies ltd - risperidone - טבליה - risperidone 1 mg - risperidone - risperidone - risperidex is indicated for the management of schizophrenia and the manifestations of psychotic disorders. the antipsychotic efficacy of risperdone was established in short-term (6 to 8 weeks) controlled trials of schizophrenic inpatients. risperidex is also effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response. risperidex is indicated for the treatment of psychotic manifestations of dementia. conduct and other disruptive disorders: treatment of behavioral disorders expressed by impulse control disorders or self-alienated-aggressive or treatment- requiring behavioral disorders with reduced or substandard intelligence. treatment should not be given to children under the age of 5 years. risperidex is indicated for the treatment of mania in bipolar disorder. these episodes are characterized by symptoms such as elevated expansive or irritable mood inflated self-esteem decreased need for sleep pressured speech racing thoughts distract

İsrail - İbranice - Ministry of Health

dexcel pharma technologies ltd - risperidone - קפליות - risperidone 2 mg - risperidone - risperidone - risperidex is indicated for the management of schizophrenia and the manifestations of psychotic disorders. the antipsychotic efficacy of risperdone was established in short-term (6 to 8 weeks) controlled trials of schizophrenic inpatients. risperidex is also effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response. risperidex is indicated for the treatment of psychotic manifestations of dementia. conduct and other disruptive disorders: treatment of behavioral disorders expressed by impulse control disorders or self-alienated-aggressive or treatment- requiring behavioral disorders with reduced or substandard intelligence. treatment should not be given to children under the age of 5 years. risperidex is indicated for the treatment of mania in bipolar disorder. these episodes are characterized by symptoms such as elevated expansive or irritable mood inflated self-esteem decreased need for sleep pressured speech racing thoughts distract

İsrail - İbranice - Ministry of Health

dexcel pharma technologies ltd - risperidone - טבליה - risperidone 3 mg - risperidone - risperidone - risperidex is indicated for the management of schizophrenia and the manifestations of psychotic disorders. the antipsychotic efficacy of risperdone was established in short-term (6 to 8 weeks) controlled trials of schizophrenic inpatients. risperidex is also effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response. risperidex is indicated for the treatment of psychotic manifestations of dementia. conduct and other disruptive disorders: treatment of behavioral disorders expressed by impulse control disorders or self-alienated-aggressive or treatment- requiring behavioral disorders with reduced or substandard intelligence. treatment should not be given to children under the age of 5 years. risperidex is indicated for the treatment of mania in bipolar disorder. these episodes are characterized by symptoms such as elevated expansive or irritable mood inflated self-esteem decreased need for sleep pressured speech racing thoughts distract

İsrail - İbranice - Ministry of Health

dexcel pharma technologies ltd - risperidone - קפליות - risperidone 4 mg - risperidone - risperidone - risperidex is indicated for the management of schizophrenia and the manifestations of psychotic disorders. the antipsychotic efficacy of risperdone was established in short-term (6 to 8 weeks) controlled trials of schizophrenic inpatients. risperidex is also effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response. risperidex is indicated for the treatment of psychotic manifestations of dementia. conduct and other disruptive disorders: treatment of behavioral disorders expressed by impulse control disorders or self-alienated-aggressive or treatment- requiring behavioral disorders with reduced or substandard intelligence. treatment should not be given to children under the age of 5 years. risperidex is indicated for the treatment of mania in bipolar disorder. these episodes are characterized by symptoms such as elevated expansive or irritable mood inflated self-esteem decreased need for sleep pressured speech racing thoughts distract

İsrail - İbranice - Ministry of Health

unipharm ltd, israel - risperidone - טבליות מצופות - risperidone 1 mg - risperidone - risperidone - risperidone is indicated for the management of schizophrania and manifestation of psychotic disorders. the antipsychotic efficacy of risperidone was established in short-term (6 to 8 weeks) controlled trials of schizophrenic inpatients. risperidone is also effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response. risperidone is indicated for the treatment of psychotic manifestations of dementia. conduct and other disruptive disorders: treatment of behavioral disorders expressed by impulse control disorders or self-alienated-aggressive or treatment- requiring behavioral disorders with reduced or substandard intelligence. treatment should not be given to children under the age of 5 years. risperidone is indicated for the treatment of mania in bipolar disorder. these episodes are characterized by symptoms such as elevated expansive or irritable mood inflated self-esteem decreased need for sleep pressured speech racing thoughts distract

İsrail - İbranice - Ministry of Health

unipharm ltd, israel - risperidone - טבליות מצופות - risperidone 2 mg - risperidone - risperidone - risperidone is indicated for the management of schizophrania and manifestation of psychotic disorders. the antipsychotic efficacy of risperidone was established in short-term (6 to 8 weeks) controlled trials of schizophrenic inpatients. risperidone is also effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response. risperidone is indicated for the treatment of psychotic manifestations of dementia. conduct and other disruptive disorders: treatment of behavioral disorders expressed by impulse control disorders or self-alienated-aggressive or treatment- requiring behavioral disorders with reduced or substandard intelligence. treatment should not be given to children under the age of 5 years. risperidone is indicated for the treatment of mania in bipolar disorder. these episodes are characterized by symptoms such as elevated expansive or irritable mood inflated self-esteem decreased need for sleep pressured speech racing thoughts distract

İsrail - İbranice - Ministry of Health

unipharm ltd, israel - risperidone - טבליות מצופות - risperidone 3 mg - risperidone - risperidone - risperidone is indicated for the management of schizophrania and manifestation of psychotic disorders. the antipsychotic efficacy of risperidone was established in short-term (6 to 8 weeks) controlled trials of schizophrenic inpatients. risperidone is also effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response. risperidone is indicated for the treatment of psychotic manifestations of dementia. conduct and other disruptive disorders: treatment of behavioral disorders expressed by impulse control disorders or self-alienated-aggressive or treatment- requiring behavioral disorders with reduced or substandard intelligence. treatment should not be given to children under the age of 5 years. risperidone is indicated for the treatment of mania in bipolar disorder. these episodes are characterized by symptoms such as elevated expansive or irritable mood inflated self-esteem decreased need for sleep pressured speech racing thoughts distract

İsrail - İbranice - Ministry of Health

unipharm ltd, israel - risperidone - טבליות מצופות - risperidone 4 mg - risperidone - risperidone - risperidone is indicated for the management of schizophrania and manifestation of psychotic disorders. the antipsychotic efficacy of risperidone was established in short-term (6 to 8 weeks) controlled trials of schizophrenic inpatients. risperidone is also effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response. risperidone is indicated for the treatment of psychotic manifestations of dementia. conduct and other disruptive disorders: treatment of behavioral disorders expressed by impulse control disorders or self-alienated-aggressive or treatment- requiring behavioral disorders with reduced or substandard intelligence. treatment should not be given to children under the age of 5 years. risperidone is indicated for the treatment of mania in bipolar disorder.these episodes are characterized by symptoms such as elevated expansive or irritable mood inflated self-esteem decreased need for sleep pressured speech racing thoughts distracti